Serum Endothelin-1 as biomarker in oral cancer - a case control study | Abstract
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

mobil porno türkçe altyazılı porno

Serum Endothelin-1 as biomarker in oral cancer - a case control study

Author(s): Sumaiya Irfan*, Nishi Tandon, A.N.Srivastava, Richa Sharma, Vijay Kumar


Worldwide, cancers of the oral cavity and pharynx are the 6th most common type & it is a major problem in the Indian subcontinent. Endothelin-1 (ET-1) is a potent vasoconstrictor involved not only in vascular biology but also in carcinogenesis. Serum Endothelin-1 level have been studied in various human cancers like colon & breast. To evaluate significance of serum Endothelin in oral cancer we undertook a case control study. A total of 48 subjects 24 controls and 24 oral cancers were enrolled for the study. Serum Endothelin-1 levels were evaluated by ELISA. The results showed that there was significant difference in serum Endothelin-1 levels in oral cancer and control. Therefore we conclude that serum Endothelin -1 has a potential role as a serum marker for oral cancer progression.

Share this article

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.

International Journal of Bioassays [ISSN: International Journal of Bioassays] is licensed under
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© Copyright 2012-2022. All rights reserved.

tempobet giriş tipobet 365 tipobet giriş adresi tipobet e yeni giriş

wormax io